insights_auto
Why is GALT up 3.60%?
Dive Deeperchevron_right
GALT:NASDAQ
Galectin Therapeutics Inc. Common Stock
$3.45
arrow_upward
+3.60%(+0.12) 1D
Nov 3, 11:22:29 AM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GALT...
Open
$3.33
High
$3.50
Low
$3.33
Mkt. cap
347.93M
Avg. vol.
201.31K
Volume
38.18K
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
Open
$3.33
High
$3.50
Low
$3.33
Mkt. cap
347.93M
Avg. vol.
201.31K
Volume
38.18K
52-wk high
$7.13
52-wk low
$2.02
EPS
-$0.43
Beta
0.53
Shares outstanding
100.85M
No. of employees
9
News stories
From web sources and news partners
TradingView
·
1 hour ago
Quantum BioPharma (NASDAQ: QNTM) Draws ‘Men’s Fitness’ Spotlight as Unbuzzd Trial Shows Early Promise
Local 3 News
·
1 hour ago
RAW: NYSE: OPENING BELL (TUESDAY)
Bloomberg.com
·
1 hour ago
Goldman’s Molavi Says 60% of S&P 500 Is in Bear Market Territory
Reuters
·
52 minutes ago
S&P 500, Nasdaq edge higher ahead of midterm results; Apple falls
About Galectin Therapeutics Inc. Common Stock
CEO-
Employees9
Founded2000
HeadquartersNorcross, Georgia, United States
SectorBiotechnology
Websitegalectintherapeutics.com